A team led by Neil King, a biochemistry professor at the University of Washington School of Medicine, is now exploring a new approach to COVID vaccines: using mRNA to let the body assemble its own ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 14, 2025 /EINPresswire.com/ -- Ribonucleic Acid (RNA)-Based Oncolytic Therapy Market Growth Forecast: What To Expect By 2025? In recent years, the ...

A team of scientists has mapped the regions surrounding stem cells in planarians—small flatworms that are famous for being ...

A review maps high throughput strategies that link automation, microfluidics, and barcoding into a unified pipeline, enabling ...

An example of this conflict occurred in the 1920s when Trofim Lysenko, a Soviet biologist, rejected natural selection in ...

Moderna faces significant uncertainty ahead of Q3 earnings, with heavy reliance on COVID vaccine revenues and limited ...

The move came after the FDA approved updated shots only for people aged 65 and over and those at risk of severe disease. The ...

Kernal has been awarded up to $48M funding to accelerate the development of KR-402, a next-generation in vivo CAR T-cell ...

Up to €95 million in blended EIB and EC financing will help BioNTech advance its mRNA manufacturing site in Kigali, Rwanda.The project aims to strengthen Africa’s ability to produce investigational or ...

More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

University of Cincinnati researchers recently published a study in the journal BMC Neurology that sheds more light on the ...